EHRET, F.; ABID, F. B.; RIBEIRO, V. T.; BODDEN, R.; MALUF, F. C.; LARCO-CASTILLA, P.; NAUD, L. M.; FERRAZ DE PAULA SOARES, C.; SHAIKH, E.; VALENTE DE CAMARGO, L.; RIDOLFI, F. M. The IDEAL trial - a study protocol for a phase III randomized, double-blinded clinical trial assessing the ultra-short antibiotic prophylaxis of Isoniazid and Rifapentine in non-immunosuppressed patients with newly diagnosed latent tuberculosis. Principles and Practice of Clinical Research, [S. l.], v. 6, n. 1, p. 9–14, 2020. Disponível em: https://journal2.teste.pro.br/index.php/ppcrjournal/article/view/96. Acesso em: 20 sep. 2024.